Thrivent Financial for Lutherans’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,175
| Closed | -$83K | – | 2479 |
|
|
2021
Q2 | $83K | Sell |
13,175
-20,670
| -61% | -$130K | ﹤0.01% | 2438 |
|
|
2021
Q1 | $262K | Sell |
33,845
-56,757
| -63% | -$439K | ﹤0.01% | 2417 |
|
|
2020
Q4 | $593K | Hold |
90,602
| – | – | ﹤0.01% | 2057 |
|
|
2020
Q3 | $602K | Buy |
90,602
+41,078
| +83% | +$273K | ﹤0.01% | 1871 |
|
|
2020
Q2 | $412K | Hold |
49,524
| – | – | ﹤0.01% | 1989 |
|
|
2020
Q1 | $380K | Buy |
+49,524
| New | +$380K | ﹤0.01% | 1868 |
|